Christopher Loose compensation by year
Korro Bio Summary Compensation Table · all 4 fiscal years held| Component | FY2018 | FY2019 | FY2022 | FY2023 |
|---|---|---|---|---|
| Salary | $316,325 | $379,167 | $480,344 | $294,211 |
| Bonus | $55,000 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $604,500 | $533,358 |
| Option awards | $87,954 | $2,278,077 | $226,580 | $0 |
| Non-equity incentive | $113,750 | $230,000 | $192,138 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $5,105 | $7,271 | $15,250 | $752,905 |
| Total | $578,134 | $2,894,515 | $1,518,812 | $1,580,474 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Korro Bio, Inc. DEF 14A filed April 29, 2024, accession 0001193125-24-119912, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Korro Bio, Inc. filed document, accession 0001193125-24-119912. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.
Korro Bio’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| David Lucchino | Former President and Chief Executive Officer(5) | $3,878,265 |
| Ram Aiyar | Chief Executive Officer and President | $2,858,230 |
| Steven Colletti | Chief Scientific Officer(9) | $1,647,368 |
| Christopher Loose · this page | Former Chief Scientific Officer(11) | $1,580,474 |
| Vineet Agarwal | Chief Financial Officer | $1,322,891 |
The full Korro Bio compensation record
free company briefThis page is one person within Korro Bio's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Korro Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.